足球中的标题:对标题发病率研究中使用的描述符,定义和报告方法的系统审查
Kerry Peek1, Andrew Ross1,2, Thor Einar Andersen3,4
1Sydney School of Health Sciences, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia.
Science & medicine in football
|June 10, 2024
概括
足球标题发病率研究缺乏标准化的定义和报告方法. 这次审查强调了头条如何定义和数据收集的不一致性,阻碍了研究比较和未来体育研究.
科学领域:
- 运动科学 运动科学 运动科学
- 生物力学 生物力学
- 足球研究 足球研究
背景情况:
- 足球中头部发作是研究的一个关键领域.
- 了解头部机制和频率对于玩家安全和性能分析至关重要.
- 现有的文献缺乏定义和测量头部冲击的一致方法.
研究的目的:
- 系统地审查足球标题发病率研究中的标题描述符和报告方法.
- 为了确定数据收集和分析标题事件的不一致性.
- 为标准化研究实践提供建议.
主要方法:
- 在五个电子数据库 (MEDLINE,CINAHL,EMBASE,SPORTDiscus,Web of Science) 进行系统搜索.
- 纳入报告足球中头部发病率的研究,直到2023年9月.
- 研究方法,定义和报告标准的描述性分析.
主要成果:
- 只有61%的研究定义了标题,23%提供了操作定义.
- 报告的标题描述符和编码选项存在显著差异.
- 研究和玩家人口统计数据 (例如年份,国家) 的报告不一致.
- 在使用惯性测量单位收集数据时,视觉识别至关重要.
- 报告方法缺乏标准化,使跨研究比较变得复杂.
结论:
- 对于足球中头球的标准化,国际支持的操作定义非常需要.
- 建议为标题发病率研究制定最低报告标准.
- 标准化将提高足球标题研究的可靠性和可比性.
相关概念视频
Statistical Methods for Analyzing Epidemiological Data
353
Epidemiological data primarily involves information on specific populations' occurrence, distribution, and determinants of health and diseases. This data is crucial for understanding disease patterns and impacts, aiding public health decision-making and disease prevention strategies. The analysis of epidemiological data employs various statistical methods to interpret health-related data effectively. Here are some commonly used methods:
353
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
125
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
125
Bias in Epidemiological Studies
242
Biases can arise at various stages of research, from study design and data collection to analysis and interpretation. Recognizing and addressing these biases is essential to ensure the validity and reliability of epidemiological findings.Broadly speaking, biases in epidemiology fall into three main categories: selection bias, information bias, and confounding. A more detailed description of possible biases is:
242
Strategies for Assessing and Addressing Confounding
92
Confounding is a critical issue in epidemiological studies, often leading to misleading conclusions about associations between exposures and outcomes. It occurs when the relationship between the exposure and the outcome is mixed with the effects of other factors that influence the outcome. Given that, addressing confounding is of high importance for drawing accurate inferences in research.
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
Confounding can be addressed at both the design phase of a study and through analytical methods after data...
92
Prevalence and Incidence
458
In statistical epidemiology and health sciences, two essential metrics—prevalence and incidence—are fundamental for understanding disease dynamics within a population. These measures enable public health officials, epidemiologists, and researchers to assess the burden of diseases, allocate resources effectively, and design impactful public health policies and interventions.
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
Prevalence indicates the proportion of individuals in a population who have a specific disease or health...
458
Hazard Ratio
111
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
For example, in a clinical trial...
111


